Jatinder Lamba
ASO DEAN & PROF
PH-PHARMTHERAPY TRNSL RSCH
GRANTS
- GRANTVascularized fetal liver-hematopoietic niche-on-chip to decode erythroid dysregulation in Down syndromeNational Institute of Health Niddk13 Jan 2026 - 30 Nov 2026
- GRANTCDKN2A Signaling in Ewing SarcomaFlorida Department of Health Live Like Bella22 Aug 2025 - 31 Jul 2028
- GRANTThe Florida Summer Training in Research and Oncology for the Next Generation of Researchers (STRONGER) ProgramNational Institute of Health Nci24 Jun 2025 - 31 May 2030
- GRANTA Multi-Institutional Study of Asparaginase Premedication, Hypersensitivity, and Therapeutic Drug Monitoring in Pediatric Patients with Acute Lymphophoblastic Leukemia or LymphomaMemorial Pediatric Subspecialty Faculty21 Mar 2025 - 28 Feb 2026
- GRANTPharmacogenomics to predict outcome and address racial disparity in pediatric AML.National Institute of Health Nci1 Mar 2024 - 28 Feb 2025
- GRANT2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity CenterNational Institute of Health Nci19 Sep 2023 - 31 Aug 2028
- GRANTTargeting ER Stress in Pediatric Acute Myeloid LeukemiaFlorida Department of Health Live Like Bella8 Sep 2023 - 31 Mar 2025
- GRANTCRISPR Synthetic Lethality Screen Identifies Genomic Resistant/Sensitive Modulators of Standard Chemotherapy in Pediatric Acute Myeloid Leukemia (pAML)15 Jun 2023 - 31 Aug 2025
- GRANTIntegrated Systems Biology of Pediatric AMLNational Institute of Health Nci15 Dec 2022 - 30 Nov 2027
- GRANTThe role of ALKBH5-mediated RNA demethylation in the maintenance of genomic stability in HSPCsNational Institute of Health Niddk20 Jul 2022 - 28 Jul 2025
- GRANTPatterns of resistance to initial therapeutic treatment in Ewing’s SarcomaHematology/Oncology Pharmacy Association Foundation26 May 2022 - 25 May 2025
- GRANTUltrasound elastogram assessment of liver fibrosis in children and adolescents/young adults (AYA) receiving chemotherapy or allogeneic bone marrow transplantation, and identification of risk factors for liver injuryFlorida Department of Health Live Like Bella23 Mar 2022 - 31 Mar 2025
- GRANTGenomics of AML PrognosisNational Institute of Health Nci23 Jul 2021 - 30 Jun 2027
- GRANTSBF-ACS RFA: Transcriptomic and pharmacogenetic scores to guide therapy in pediatric AMLSt. Baldrick's Foundation1 Jul 2021 - 30 Jun 2023People funded by this grant:
- Lamba JK
- GRANTTranscriptomic and pharmacogenetic scores to guide therapy in pediatric AMLAmerican Cancer Society1 Jul 2021 - 31 Dec 2023People funded by this grant:
- Lamba JK
- GRANTTranscriptomic and pharmacogenetic scores to guide therapy in pediatric AMLAmerican Cancer Society9 Apr 2021 - 31 Dec 2023
- GRANTPharmacokinetics and Pharmacogenomics of Pediatric ChemotherapeuticsCancer League2 Oct 2020 - 31 Jul 2021
- GRANTPharmacogenomic Drivers of Efficacy in Anti-CD33 Immunotherapeutic Treatment StrategiesAmerican Foundation for Pharm Education29 Jul 2020 - 31 Aug 2021
- GRANTAFPE Fellowship: Rho Chi -AFPE Graduate Fellowship28 Jul 2020 - 31 Aug 2021
- GRANTAsparaginase Premedication, Hypersensitivity, and Therapeutic Drug Monitoring in Pediatric Patients with Acute Lymphoblastic Leukemia or LymphomaMemorial Pediatric Subspecialty Faculty25 Nov 2019 - 31 Dec 2023
- GRANTPersonalizing CD33-directed immunotherapy for pediatric AMLSt Baldricks Foundation16 Aug 2019 - 30 Jun 2020
- GRANTPersonalizing CD33-directed Immunotherapy for Pediatric AMLBlood Cancer United13 May 2019 - 30 Jun 2022
- GRANTPharmacogenomics and Toxicities of Thiotepa, Busulfan and Fludarabine in Pediatric HSCT RecipientsFlorida Department of Health Live Like Bella5 Apr 2019 - 31 Mar 2022
- GRANT2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity CenterNational Institute of Health Nci17 Sep 2018 - 31 Aug 2023
- GRANTOR-DRPD-ROD2018: Development of Leukemia-Oncotype Prototype CARS (Cytarabine AML Response Score) for Prediction of Relapse Risk in AMLUF Research26 Apr 2018 - 31 May 2021